Benitec Biopharma Inc share price logo

Benitec Biopharma Inc Share Price

NASDAQ: BNTC

Small Cap

$13.98

+0.13

(+0.94%)

Live

as on

Benitec Biopharma Inc Stock Performance

as on September 16, 2025 at 12:28 am IST

  • Day's Low

    $13.49
    $13.98
    downward going graph

    3.51%

    Downside

  • 52 Week's Low

    52 Week's High

    $8.2
    $17.15
    downward going graph

    41.34%

    Downside

    22.68%

    Upside

    downward going graph

Benitec Biopharma Inc share price movements today

Previous Close
$13.85
Open
$13.81
Volume
198.9K
Day's Low - High
$13.49 - $13.98
52 Week Low - High
$8.2 - $17.15

Benitec Biopharma Inc Historical Returns

1 Month Return
+ 6.46 %
3 Month Return
-15.96 %
1 Year Return
+ 69.94 %
3 Year Return
+ 89.91 %
5 Year Return
-86.36 %

Benitec Biopharma Inc Stock Fundamentals & Key Indicators

Check Benitec Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$363.6M

EPS (TTM)

-1.2443

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.19

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-30.1M

Revenue (TTM)

7.0K

Profit Margin

0.00%

Return On Equity TTM

257500.00%

Benitec Biopharma Inc Stock Valuation

Track how Benitec Biopharma Inc P/E has moved over time to understand its valuation trends.

Benitec Biopharma Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (-4.19x)

September 15, 2025

Highest (-0.39x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -4.19x

Benitec Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Benitec Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$363.6M-86.36%-4.190.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Benitec Biopharma Inc Stock including INR - Dollar returns

The Benitec Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Benitec Biopharma Inc investment value today

Current value as on today

₹1,76,519

Returns

₹76,519

(+76.52%)

Returns from Benitec Biopharma Inc Stock

₹71,534 (+71.53%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Benitec Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Benitec Biopharma Inc. Average target price of $25.71

Benitec Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Benitec Biopharma Inc.

What analysts predicted

45.62%UPSIDE

Target Price

$25.71

Current Price

$13.98

Analyzed by

7 Analysts

Target

$25.71

Benitec Biopharma Inc target price $25.71, a slight upside of 45.62% compared to current price of $13.98. According to 7 analysts rating.

Benitec Biopharma Inc Stock's Interest Amongst Investors

Search interest for Benitec Biopharma Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-67% versus previous 30 day period

Benitec Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
0
0
0
-
-
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-5
-4
-4
-5
-6
-4
-5
-5
-8
-10
EBITDA
-5
-4
-4
-5
-6
-4
-4
-4
-8
-10
Interest Expense
0
0
0
0
0
0
-
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-4
-4
-5
-6
-4
-4
-5
-7
-9
Income Tax Expense
0
0
0
0
0
-
0
-
-7
-
Net Income
-3
-2
-3
-3
-4
-2
-3
-3
-7
-9
Net Profit Margin
-37228.57%
-8142.59%
-66585.71%
0.00%
0.00%
-71316.67%
0.00%
0.00%
0.00%
0.00%

Benitec Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2015
Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Total Revenue
0
0
0
0
7
0
0
0
0
0
Gross Profit
0
0
0
0
7
0
0
0
0
0
Operating Income
-13
-24
-15
-8
2
-8
-13
-17
-19
-22
EBITDA
-7
-13
-4
-8
2
-7
-13
-17
-19
-21
Interest Expense
-
-
-
-
0
0
0
0
0
0
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-8
-18
-4
-8
2
-8
-13
-18
-19
-21
Income Tax Expense
0
-9
0
0
0
0
0
0
0
0
Net Income
-6
-13
-3
-6
1
-5
-10
-12
-13
-14
Net Profit Margin
-1064.66%
-5340.09%
-970.99%
-1877.42%
25.34%
-8557.73%
-23528.81%
-24942.47%
-26082.67%
-10069.91%

Benitec Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
-4
-4
-5
-6
-4
-4
-5
-7
-9
Operating Cash Flow
-4
-4
-4
-5
-6
-3
-4
-7
-3
Investing Cash Flow
0
0
-
-
0
0
-
0
0
Financing Cash Flow
0
0
27
0
0
40
21
17
28
Change in Cash
-3
-4
23
-5
-6
36
16
10
25

Benitec Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Net Income
-18
-4
-8
2
-8
-13
-18
-19
-21
Operating Cash Flow
-20
-8
-8
4
-7
-12
-15
-18
-19
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
17
6
6
0
1
22
16
16
68
Change in Cash
-2
0
0
4
-5
9
-15
-1
48

Global Institutional Holdings in Benitec Biopharma Inc

Funds
Holdings
Suvretta Capital Management, LLC
37.62%
HHG PLC
11.12%
Franklin Resources Inc
10.9%
Adage Capital Partners Gp LLC
7.51%
Nantahala Capital Management, LLC
3.19%

Insights on Benitec Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 33.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 5.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -4.27M → -9.35M (in $), with an average decrease of 22.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BNTC stock has moved down by -16.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 54.0K → 6.0K (in $), with an average decrease of 50.7% per quarter

About Benitec Biopharma Inc

benitec biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. our transformational technology, ddrnai, targets and ‘turns off’ specific genes related to disease, providing lasting treatment and potentially cure with a single dose. compared to traditional approaches to rna intereference, ddrnai is easier to deliver, safer to us, more targeted and more efficient. benitec has a pipeline of in-house and partnered drug development programs based on ddrnai, including hepatitis c and b and cancer-associated pain. ddrnai has the potential to silence genes related to thousands of human diseases and is protected by over 40 global patents. the technology is available from benitec under a variety of licence options.
OrganisationBenitec Biopharma Inc
Headquarters3940 Trust Way, Hayward, CA, United States, 94545
IndustryHealth Technology
CEODr. Jerel A. Banks M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Benitec Biopharma Inc

Name

Title

Dr. Claudia Kloth Ph.D.

Senior Vice President of Manufacturing

Dr. Jerel A. Banks M.D., Ph.D.

Executive Chairman & CEO

Ms. Megan Joan Boston B.Com., C.A.

CFO & Director

Ms. Sophie Mukadam

Chief Operating Officer

Dr. Michael Graham

Head of Discovery & Founding Scientist

FAQs

What is Benitec Biopharma Inc share price today?

Benitec Biopharma Inc share price today is $13.98 as on . Benitec Biopharma Inc share today touched a day high of $13.98 and a low of $13.49.

What is the 52 week high and 52 week low for Benitec Biopharma Inc share?

Benitec Biopharma Inc share touched a 52 week high of $17.15 on and a 52 week low of $8.2 on . Benitec Biopharma Inc stock price today i.e. is trending at $13.98,which is 18.48% down from its 52 week high and 70.49% up from its 52 week low.

What is Benitec Biopharma Inc's market capitalisation today?

Benitec Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Benitec Biopharma Inc Stock (BNTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Benitec Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Benitec Biopharma Inc Shares that will get you 0.1073 shares as per Benitec Biopharma Inc share price of $13.98 per share as on September 16, 2025 at 12:28 am IST.

What is the minimum amount required to buy Benitec Biopharma Inc Stock (BNTC) from India?

Indian investors can start investing in Benitec Biopharma Inc (BNTC) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Benitec Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Benitec Biopharma Inc share’s latest price of $13.98 as on September 16, 2025 at 12:28 am IST, you will get 0.7153 shares of Benitec Biopharma Inc. Learn more about fractional shares .

What are the returns that Benitec Biopharma Inc has given to Indian investors in the last 5 years?

Benitec Biopharma Inc stock has given -86.36% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?